-
1
-
-
50249119572
-
Immunophenotyping of serous carcinoma of the female genital tract
-
Nofech-Mozes S, Khalifa MA, Ismiil N, Saad RS, Hanna WM, Covens A, Ghorab Z. Immunophenotyping of serous carcinoma of the female genital tract, Mod Pathol, 2008, 21(9): 1147-1155.
-
(2008)
Mod Pathol
, vol.21
, Issue.9
, pp. 1147-1155
-
-
Nofech-Mozes, S.1
Khalifa, M.A.2
Ismiil, N.3
Saad, R.S.4
Hanna, W.M.5
Covens, A.6
Ghorab, Z.7
-
2
-
-
58249089224
-
Lack of prognostic significance of HER-2/neu in early epithelial ovarian cancer
-
Sueblinvong T, Manchana T, Khemapech N, Triratanachat S, Termrungruanglert W, Tresukosol D. Lack of prognostic significance of HER-2/neu in early epithelial ovarian cancer, Asian Pac J Cancer Prev, 2007, 8(4):502-506.
-
(2007)
Asian Pac J Cancer Prev
, vol.8
, Issue.4
, pp. 502-506
-
-
Sueblinvong, T.1
Manchana, T.2
Khemapech, N.3
Triratanachat, S.4
Termrungruanglert, W.5
Tresukosol, D.6
-
3
-
-
10044232731
-
Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer
-
Nielsen JS, Jakobsen E, Hølund B, Bertelsen K, Jakobsen A. Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer, Int J Gynecol Cancer, 2004, 14(6):1086-1096.
-
(2004)
Int J Gynecol Cancer
, vol.14
, Issue.6
, pp. 1086-1096
-
-
Nielsen, J.S.1
Jakobsen, E.2
Hølund, B.3
Bertelsen, K.4
Jakobsen, A.5
-
4
-
-
33745425273
-
HER-2/neu and bcl-2 in ovarian carcinoma: Clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival
-
Raspollini MR, Amunni G, Villanucci A, Castiglione F, Rossi Degl'Innocenti D, Baroni G, Paglierani M, Taddei GL. HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival, Appl Immunohistochem Mol Morphol, 2006, 14(2):181-186.
-
(2006)
Appl Immunohistochem Mol Morphol
, vol.14
, Issue.2
, pp. 181-186
-
-
Raspollini, M.R.1
Amunni, G.2
Villanucci, A.3
Castiglione, F.4
Rossi Degl'Innocenti, D.5
Baroni, G.6
Paglierani, M.7
Taddei, G.L.8
-
5
-
-
50349096101
-
Epidermal growth factor receptor expression in serous ovarian carcinoma: An immunohistochemical study with galectin-3 and cyclin D1 and outcome
-
Brustmann H. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome, Int J Gynecol Pathol, 2008, 27(3):380-389.
-
(2008)
Int J Gynecol Pathol
, vol.27
, Issue.3
, pp. 380-389
-
-
Brustmann, H.1
-
6
-
-
0026484997
-
Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary
-
Wang DP, Konishi I, Koshiyama M, Nanbu Y, Iwai T, Nonogaki H, Mori T, Fujii S. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary, Virchows Arch A Pathol Anat Histopathol, 1992, 421(5):393-400.
-
(1992)
Virchows Arch A Pathol Anat Histopathol
, vol.421
, Issue.5
, pp. 393-400
-
-
Wang, D.P.1
Konishi, I.2
Koshiyama, M.3
Nanbu, Y.4
Iwai, T.5
Nonogaki, H.6
Mori, T.7
Fujii, S.8
-
7
-
-
2642573006
-
-
(eds), World Health Organization Classification of Tumours, IARC Press, Lyon,
-
Tavassoli FA, Devilee P (eds). Pathology and genetics of tumours of the breast and female genital organs, World Health Organization Classification of Tumours, IARC Press, Lyon, 2003.
-
(2003)
Pathology and genetics of tumours of the breast and female genital organs
-
-
Tavassoli, F.A.1
Devilee, P.2
-
8
-
-
33746742412
-
Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma
-
Lassus H, Sihto H, Leminen A, Joensuu H, Isola J, Nupponen NN, Butzow R. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma, J Mol Med (Berl), 2006, 84(8): 671-681.
-
(2006)
J Mol Med (Berl)
, vol.84
, Issue.8
, pp. 671-681
-
-
Lassus, H.1
Sihto, H.2
Leminen, A.3
Joensuu, H.4
Isola, J.5
Nupponen, N.N.6
Butzow, R.7
-
9
-
-
22944486725
-
An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: Significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms
-
O'Neill CJ, Deavers MT, Malpica A, Foster H, McCluggage WG. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms, Am J Surg Pathol, 2005, 29(8):1034-1041.
-
(2005)
Am J Surg Pathol
, vol.29
, Issue.8
, pp. 1034-1041
-
-
O'Neill, C.J.1
Deavers, M.T.2
Malpica, A.3
Foster, H.4
McCluggage, W.G.5
-
10
-
-
33749144509
-
HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications
-
Villella JA, Cohen S, Smith DH, Hibshoosh H, Hershman D. HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications, Int J Gynecol Cancer, 2006, 16(5):1897-1902.
-
(2006)
Int J Gynecol Cancer
, vol.16
, Issue.5
, pp. 1897-1902
-
-
Villella, J.A.1
Cohen, S.2
Smith, D.H.3
Hibshoosh, H.4
Hershman, D.5
-
11
-
-
0035027576
-
The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma
-
Skírnisdóttir I, Sorbe B, Seidal T. The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma, Int J Gynecol Cancer, 2001, 11(2):119-129.
-
(2001)
Int J Gynecol Cancer
, vol.11
, Issue.2
, pp. 119-129
-
-
Skírnisdóttir, I.1
Sorbe, B.2
Seidal, T.3
-
12
-
-
2042427915
-
A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging
-
Skírnisdóttir I, Seidal T, Sorbe B. A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging, Int J Gynecol Cancer, 2004, 14(2):259-270.
-
(2004)
Int J Gynecol Cancer
, vol.14
, Issue.2
, pp. 259-270
-
-
Skírnisdóttir, I.1
Seidal, T.2
Sorbe, B.3
-
13
-
-
3142519839
-
Papillary serous carcinoma of the ovary: An ultrastructural and immunohistochemical study
-
Suo Z, Karbovo E, Trope CG, Metodiev K, Nesland JM. Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study, Ultrastruct Pathol, 2004, 28(3):141-147.
-
(2004)
Ultrastruct Pathol
, vol.28
, Issue.3
, pp. 141-147
-
-
Suo, Z.1
Karbovo, E.2
Trope, C.G.3
Metodiev, K.4
Nesland, J.M.5
-
14
-
-
10044270836
-
HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization
-
Heinrich JK, Böttcher-Luiz F, Andrade LL, Davidson S, Bonds L, Stephens J, Varella-Garcia M. HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization, Int J Gynecol Cancer, 2004, 14(6):1078-1085.
-
(2004)
Int J Gynecol Cancer
, vol.14
, Issue.6
, pp. 1078-1085
-
-
Heinrich, J.K.1
Böttcher-Luiz, F.2
Andrade, L.L.3
Davidson, S.4
Bonds, L.5
Stephens, J.6
Varella-Garcia, M.7
-
15
-
-
33645322927
-
Epithelial growth factor receptor status in primary and recurrent ovarian cancer
-
Stadlmann S, Gueth U, Reiser U, Diener PA, Zeimet AG, Wight E, Mirlacher M, Sauter G, Mihatsch MJ, Singer G. Epithelial growth factor receptor status in primary and recurrent ovarian cancer, Mod Pathol, 2006, 19(4):607-610.
-
(2006)
Mod Pathol
, vol.19
, Issue.4
, pp. 607-610
-
-
Stadlmann, S.1
Gueth, U.2
Reiser, U.3
Diener, P.A.4
Zeimet, A.G.5
Wight, E.6
Mirlacher, M.7
Sauter, G.8
Mihatsch, M.J.9
Singer, G.10
|